Clinical genomics · Built for IndiaLive in 5 design-partner labs

Genomic intelligence,lab-ready.

inferagen.ai is the operating system for India's diagnostic labs. Sequencing pipelines, smart human-readable reports, and direct integration with Illumina, MGI, and Oxford Nanopore — priced by the sample, not the seat.

Request a 15-min demo See a sample report

Compliance & recognitions

ISO 27001 / 9001 / 20000 certified·ABDM-ready·DPDP Act 2023 compliant·Startup India recognized·MSME-registered

Sai Diagnostics · Hyderabad

Patient summary

Report ID

IG-2026-04812

/ 100

Health risk index

2 actionable findings · 4 informational · 0 incidental

Moderatevs Indian-pop baseline

Key findings

BRCA1

c.5266dupC

Pathogenic

CYP2D6

*4 / *10

Reduced metabolizer

MTHFR

c.677C>T

Likely benign

Page 1 of 3 · Patient summary

Classified

ACMG 2015 · India-pop

Patient summary

हिन्दी · English · తెలుగు

Generated in

3 hr 47 min

BCL → signed PDF

Production benchmarks · live

Updated weekly · NA12878 + 5 design partners

3–4hrs

BCL → signed WES report

99.7%

NA12878 concordance

5×

Faster TAT vs in-house

₹0

Annual lock-in

Works with the stack India's genomics labs already use

Sequencers

Illumina
MGI
Oxford Nanopore

Compute & data

AWS Mumbai
NVIDIA Parabricks
ClinVar
ACMG 2015

Compliance

DPDP Act 2023
ABDM-FHIR
ISO 27001 / 9001 / 20000

Illumina-compatibleMGI-compatibleOxford NanoporeNVIDIA ParabricksClinVarACMG 2015ABDM-FHIRAWS MumbaiIllumina-compatibleMGI-compatibleOxford NanoporeNVIDIA ParabricksClinVarACMG 2015ABDM-FHIRAWS Mumbai

The problem

Indian labs sit on sequencers they can't fully use.

The bottleneck isn't the chemistry. It's the software stack between the sequencer and the clinician.

run_pipeline.sh

$ bwa mem ref.fa s.fq | samtools sort

$ gatk HaplotypeCaller -I out.bam

$ bcftools norm | annovar | ...

! error: tool v4.1 not reproducible

Pipelines built from shell scripts.

Most labs stitch 7+ open-source tools to go from FASTQ to a report. Reproducibility breaks.

Sample submitted → Report

DAY 14

Manual review · no audit · one-off

Reports take 5–14 days.

Manual variant review, no audit trail, no versioning. Every report is a one-off project.

40+ pages

PDFs that clinicians can't read.

40-page outputs with VCF tables, IGV screenshots, and zero patient-facing summary.

The platform

One platform. Five capabilities. Paid by the sample.

We replace the entire bioinformatics + reporting stack — and we charge for what you actually use.

Smart Reports

Vector visuals, ACMG-classified, patient summary in plain language.

Sequencing Pipelines

WES live — BCL → signed report in 3–4 hours. Multi-sample parallel.

Direct Machine Integration

Illumina, MGI, Oxford Nanopore — BCL → VCF → report.

White-label Branding

Each lab gets its logo, colors, subdomain, formats.

Wallet Pricing

Pay per sample. Recharge when low. No annual lock-in.

Our scalable multi-processing architecture supports the full clinical genomics workflow — WGS, RNA-seq / transcriptome, targeted panels, and pharmacogenomics — at the same 3–4 hour per-sample throughput. Talk to our team for onboarding on your specific test type.

The report

The report your clinicians have been waiting for.

Most genomic reports today are 40-page PDFs of VCF tables. Ours start with a one-page patient summary, then a one-page clinician summary, then the full ACMG-classified detail.

The legacy report

Status quo

40 pages of VCF tables

40+

Pages

~30 min

Read time

5–14 days

TAT

—

Patient view

Manual variant review
No audit trail
US/EU population data
PDF email attachment

The inferagen report

Live

3 pages, designed to be read

Pages

5 min

Read time

3–4 hrs

TAT

Languages

ACMG 2015 + India-pop overlay
Audit-logged sign-off
FHIR + ABDM export
Patient + clinician views

See exactly what your clinician will receive.

Sample · Hereditary breast cancer panel · PII removed · No email required

Download sample (PDF)

Why we exist

We are not a testing lab. We sell the software that labs run on.

Direct integration

3 / 3

ILMN

Illumina

MGI

ONT

Oxford Nanopore

Element + Ultima — Q3 2026

01 — Sequencer-agnostic

Illumina, MGI, Nanopore — and Element/Ultima next.

Built for the world where Illumina isn't the only sequencer in the lab.

Indian samples in db

ClinVar

0.6%

gnomAD v4

0.9%

inferagen overlay

100%

02 — Indian-population data

ClinVar + gnomAD are <1% Indian. We layer India-population allele frequencies on top.

Indian-population frequencies on every variant call — curated quarterly with our customer network.

Wallet · Sai Diagnostics

ACTIVE

Balance

₹74,200

74% of ₹1,00,000 · 132 reports left

No annual lock-in · top up anytime

03 — Wallet-priced

Indian labs have lumpy test volumes. Annual SaaS lock-in doesn't fit.

The wallet model is the Indian B2B norm: recharge ₹25K to ₹25L, consume per sample, top up when needed.

inferagen.ai is built by Orbitnexa Technologies — a Hyderabad-based AI engineering studio.

We're not a 2-person seed-stage idea. inferagen.ai is built by the engineering team at Orbitnexa Technologies Pvt Ltd — a Hyderabad-based AI engineering studio incorporated in July 2025 and recognized under Startup India.

Orbitnexa is an ISO 27001, ISO 9001, and ISO/IEC 20000 certified engineering organization, MSME-registered, with a growing portfolio of production deployments across healthcare, banking, and e-commerce. Every engineer on inferagen is hired and managed under Orbitnexa's quality and security regime.

We funded inferagen's R&D from Orbitnexa's services revenue. By the time you talk to us, you're talking to a team that has already built, audited, and shipped this product — not pitched it.